Here, we performed proof-of-principle epitope mapping of anti-rhGAA ADAs from a minimal amount of plasma from a Pompe-disease patient using a novel variant of epitope extraction with affinity purification and LC-MS with label-free quantitation. Here, AGPS is linked to glycogen storage disease II.